BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16301686)

  • 21. Mapping of an autoreactive epitope within glutamate decarboxylase using a diabetes-associated human monoclonal autoantibody and an epitope cDNA library.
    Richter W; Northemann W; Müller M; Böhm BO
    Hybridoma; 1996 Apr; 15(2):103-8. PubMed ID: 8743289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation and characterization of human monoclonal autoantibodies to glutamic acid decarboxylase.
    Hayakawa N; Premawardhana LD; Powell M; Masuda M; Arnold C; Sanders J; Evans M; Chen S; Jaume JC; Baekkeskov S; Smith BR; Furmaniak J
    Autoimmunity; 2002 Aug; 35(5):343-55. PubMed ID: 12515289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies to inhibitory synaptic proteins in neurological syndromes associated with glutamic acid decarboxylase autoimmunity.
    Gresa-Arribas N; Ariño H; Martínez-Hernández E; Petit-Pedrol M; Sabater L; Saiz A; Dalmau J; Graus F
    PLoS One; 2015; 10(3):e0121364. PubMed ID: 25774787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stiff person syndrome does not always occur with maternal passive transfer of GAD65 antibodies.
    Nemni R; Caniatti LM; Gironi M; Bazzigaluppi E; De Grandis D
    Neurology; 2004 Jun; 62(11):2101-2. PubMed ID: 15184624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unique epitopes of glutamic acid decarboxylase autoantibodies in slowly progressive type 1 diabetes.
    Kobayashi T; Tanaka S; Okubo M; Nakanishi K; Murase T; Lernmark A
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4768-75. PubMed ID: 14557453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies.
    Liimatainen S; Honnorat J; Pittock SJ; McKeon A; Manto M; Radtke JR; ; Hampe CS
    Orphanet J Rare Dis; 2018 Apr; 13(1):55. PubMed ID: 29636076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recognition of glutamic acid decarboxylase (GAD) by autoantibodies from different GAD antibody-positive phenotypes.
    Hampe CS; Hammerle LP; Bekris L; Ortqvist E; Kockum I; Rolandsson O; Landin-Olsson M; Törn C; Persson B; Lernmark A
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4671-9. PubMed ID: 11134126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-lived plasma cells and memory B cells produce pathogenic anti-GAD65 autoantibodies in Stiff Person Syndrome.
    Rizzi M; Knoth R; Hampe CS; Lorenz P; Gougeon ML; Lemercier B; Venhoff N; Ferrera F; Salzer U; Thiesen HJ; Peter HH; Walker UA; Eibel H
    PLoS One; 2010 May; 5(5):e10838. PubMed ID: 20520773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus.
    Falorni A; Gambelunghe G; Forini F; Kassi G; Cosentino A; Candeloro P; Bolli GB; Brunetti P; Calcinaro F
    J Clin Endocrinol Metab; 2000 Jan; 85(1):309-16. PubMed ID: 10634404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder.
    Martinez-Hernandez E; Ariño H; McKeon A; Iizuka T; Titulaer MJ; Simabukuro MM; Lancaster E; Petit-Pedrol M; Planagumà J; Blanco Y; Harvey RJ; Saiz A; Graus F; Dalmau J
    JAMA Neurol; 2016 Jun; 73(6):714-20. PubMed ID: 27065452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A diabetes-related epitope of GAD65: a major diabetes-related conformational epitope on GAD65.
    Myers MA; Fenalti G; Gray R; Scealy M; Tong JC; El-Kabbani O; Rowley MJ
    Ann N Y Acad Sci; 2003 Nov; 1005():250-2. PubMed ID: 14679070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterisation of an autoreactive conformational epitope on GAD65 recognised by the human monoclonal antibody b78 using a combination of phage display, in vitro mutagenesis and molecular modelling.
    O'Connor KH; Banga JP; Darmanin C; El-Kabbani O; Mackay IR; Rowley MJ
    J Autoimmun; 2006 May; 26(3):172-81. PubMed ID: 16564157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies in childhood IDDM.
    Falorni A; Ackefors M; Carlberg C; Daniels T; Persson B; Robertson J; Lernmark A
    Diabetologia; 1996 Sep; 39(9):1091-8. PubMed ID: 8877294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The PEVKEK region of the pyridoxal phosphate binding domain of GAD65 expresses a dominant B cell epitope for type 1 diabetes sera.
    Tong JC; Myers MA; Mackay IR; Zimmet PZ; Rowley MJ
    Ann N Y Acad Sci; 2002 Apr; 958():182-9. PubMed ID: 12021103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic changes of GAD65 autoantibody epitope specificities in individuals at risk of developing type 1 diabetes.
    Schlosser M; Banga JP; Madec AM; Binder KA; Strebelow M; Rjasanowski I; Wassmuth R; Gilliam LK; Luo D; Hampe CS
    Diabetologia; 2005 May; 48(5):922-30. PubMed ID: 15834701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-resolution autoreactive epitope mapping and structural modeling of the 65 kDa form of human glutamic acid decarboxylase.
    Schwartz HL; Chandonia JM; Kash SF; Kanaani J; Tunnell E; Domingo A; Cohen FE; Banga JP; Madec AM; Richter W; Baekkeskov S
    J Mol Biol; 1999 Apr; 287(5):983-99. PubMed ID: 10222205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies.
    Ali F; Rowley M; Jayakrishnan B; Teuber S; Gershwin ME; Mackay IR
    J Autoimmun; 2011 Sep; 37(2):79-87. PubMed ID: 21680149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High definition profiling of autoantibodies to glutamic acid decarboxylases GAD65/GAD67 in stiff-person syndrome.
    Burbelo PD; Groot S; Dalakas MC; Iadarola MJ
    Biochem Biophys Res Commun; 2008 Feb; 366(1):1-7. PubMed ID: 18047830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of CD4+ T cells specific for glutamic acid decarboxylase (GAD65) and proinsulin in a patient with stiff-person syndrome but without type 1 diabetes.
    Hänninen A; Soilu-Hänninen M; Hampe CS; Deptula A; Geubtner K; Ilonen J; Knip M; Reijonen H
    Diabetes Metab Res Rev; 2010 May; 26(4):271-9. PubMed ID: 20503259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinically disparate stiff-person syndrome with GAD65 autoantibody in a father and daughter.
    Burns TM; Jones HR; Phillips LH; Bugawan TL; Erlich HA; Lennon VA
    Neurology; 2003 Nov; 61(9):1291-3. PubMed ID: 14610143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.